The Calgary Stroke Program, a joint University of Calgary and Alberta Health Services initiative at Foothills Medical Centre, has been involved with three papers published this week in The Lancet and ...
Neuroprotection is any therapy that prevents, retards, or reverses apoptosisassociated neuronal cell death resulting from primary neuronal lesions. Although more than 500 products have been ...
Neurodegenerative disorders are defined by progressive neuronal dysfunction and death, in which oxidative stress is recognized as a central contributor to ...
Glaucoma, the second leading cause of worldwide blindness, is a progressive optic neuropathy characterized by a loss of retinal ganglion cells and their axons beyond typical age-related baseline loss.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results